Atrial fibrillation (AF) is one of the most common arrhythmias in adults, and its continued rise
in the United States is complicated by the increased incidence and prevalence of several AF …

Background This systematic overview was commissioned by England's Department of
Health and Social Care (DHSC) to assess the evidence on direct (previously 'novel') oral …

Obesity is highly prevalent, and it is expected to grow considerably in the United States. The
association between obesity and an increased risk of complications following total joint …

Direct oral anticoagulants (DOACs) are a favored treatment to prevent stroke in patients with
atrial fibrillation (AF). There are limited data concerning the efficacy and safety of DOACs in …

Background: Atrial fibrillation (AF) and obesity are common conditions globally; yet, there
remains suboptimal pharmacological management contributing to high rates of …

Background Atrial fibrillation (AF) and obesity affect over 60 and 650 million people,
respectively. Aim This study aimed to explore clinician practices, beliefs, and attitudes …

Purpose: The oculofacial plastic surgeon will more frequently encounter challenges related
to overweight and obese patients as the incidence rises. There is a paucity of data in the …

Abstract Background and Aim Obesity affects nearly 650 million adults worldwide, and the
prevalence is steadily rising. This condition has significant adverse effects on cardiovascular …

Atrial fibrillation (AF) is a cardiac condition characterized by an irregular heart rhythm, which
is increasingly prevalent in the modern era. All international guidelines strongly advise the …

Objective: The objective of the study was to discuss the controversies surrounding the use
and dosing of direct-acting oral anticoagulants (DOACs) in obese patients recognizing the …